Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127449421 | 12744942 | 1 | I | 20160715 | 20160915 | 20160915 | PER | NL-NOVEL LABORATORIES, INC-2016-03285 | NOVEL LABS | UNKNOWN, LAREB. TOPICAL CORTICOSTEROIDS AND STEROID WITHDRAWAL SYNDROME IN ATOPIC ECZEMA. LAREB-QUART-REP. 2016;. | 0.00 | F | Y | 0.00000 | 20160914 | CN | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127449421 | 12744942 | 1 | PS | Clobetasol | CLOBETASOL | 1 | Unknown | 0.5MG/G | UNKNOWN | 206075 | |||||||||
| 127449421 | 12744942 | 2 | SS | BETAMETHASONE. | BETAMETHASONE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 127449421 | 12744942 | 3 | C | Ciclesonide | CICLESONIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127449421 | 12744942 | 1 | Dermatitis atopic |
| 127449421 | 12744942 | 2 | Dermatitis atopic |
| 127449421 | 12744942 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127449421 | 12744942 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127449421 | 12744942 | Eczema | |
| 127449421 | 12744942 | Steroid withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |